ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
0.00%
S&P ASX All Technology
3,092.70
0.00%
Brent Oil
82.275
0.00%
US Dollar vs AUD
1.51378
0.00%
Bitcoin
66,460.62
0.41%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAFW)

  7. bioAffinity Technologies Inc (BIAFW) News

BIAFW

bioAffinity Technologies (BIAFW)

bioAffinity Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIAFW
DateTimeSourceHeadlineSymbolCompany
15/06/202410:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
15/06/202410:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
15/06/202410:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
12/06/202422:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFWbioAffinity Technologies Inc
06/06/202406:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIAFWbioAffinity Technologies Inc
06/06/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFWbioAffinity Technologies Inc
23/05/202406:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
23/05/202406:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
16/05/202400:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFWbioAffinity Technologies Inc
15/05/202423:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFWbioAffinity Technologies Inc
02/05/202422:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
24/04/202422:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFWbioAffinity Technologies Inc
09/04/202422:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFWbioAffinity Technologies Inc
02/04/202400:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
09/03/202404:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
07/03/202401:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
22/02/202400:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
31/01/202400:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFWbioAffinity Technologies Inc
09/01/202400:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFWbioAffinity Technologies Inc
06/12/202300:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFWbioAffinity Technologies Inc
01/12/202300:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFWbioAffinity Technologies Inc
29/11/202300:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFWbioAffinity Technologies Inc
15/11/202308:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
07/11/202300:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFWbioAffinity Technologies Inc
10/10/202323:00Business WirebioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
07/09/202322:00Business WirebioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
15/08/202307:03Business WirebioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
12/07/202322:00Business WireAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerNASDAQ:BIAFWbioAffinity Technologies Inc
15/06/202322:00Business WirebioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
22/05/202322:00Business WirebioAffinity Technologies Presents Research Findings at CYTO 2023NASDAQ:BIAFWbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAFW

Your Recent History

NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
FX
EURAUD
Euro vs AUD
ASX
WDC
Westfield
ASX
QBE
QBE Insurance
ASX
WPL
Woodside Petroleum
FX
AUDCAD
AUD vs CAD
NYSE
KO
Coca Cola
ASX
FMG
Fortescue
NYSE
MRK
Merck
ASX
ORG
Origin Energy
ASX
CSL
CSL
ASX
TLS
Telstra
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved